Estrogen receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications

Acta Oncologica

Volumn 47, Issue 4, 2008, Pages 789-794

  Talman, Maj Lis M ^a,d   Rasmussen, Birgitte B ^a   Andersen, Jørn ^b   Christensen, Ib J ^c  

^a HILLERØD HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c FINSEN LABORATORY   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CALCULATION; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; FEMALE; HOSPITAL DEPARTMENT; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK FACTOR; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; BREAST TUMOR; CHEMISTRY; METABOLISM;

AGED; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 45149122826     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801982741     Document Type: Article

References (12)

1. Jensen EV, Suzuki T, Kawashima T, Stumpf WE, Jungblut PW, DeSombre ER. A two step mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci USA 1968;59:632-8.
2. Dowset M. Estrogen receptor; methodology matters. J Clin Oncol 2006;24:5626-8.
3. Benzon N, Düring M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 2008;122:1089-94.
4. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
5. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: Correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol 2000;53:688-96.
6. Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, et al. Re-evaluating adjuvant breast cancer trials: Assessing hormone receptor status by immunohistochemical versus extraction assays. JNCI 2006;98:1571-81.
7. Andersen J, Bentzen SM, Poulsen HS. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Eur J Cancer Clin Oncol 1988;24:377-84.
8. Poulsen HS. Oestrogen receptor assay - Limitation of the method. Eur J Cancer 1981;17:495-501.
9. Thorpe SM, Poulsen HS, Pedersen KO, Rose C. Impact of standardization of estrogen and progesteron receptor assays of breast cancer biopsies in Denmark. Eur J Cancer Clin Oncol 1988;24:1263-9.
10. Poulsen HS, Ozzello L, King WJ, Greene GL. The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue. J Histochem Cytochem 1985;33:87-92.
11. www.dbcg.dk
12. www.NordiQC.org